LESLIE MEAD: Open Payments
NPI 1194272435 · BUSHNELL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 16 payments from 10 companies in 2025. Trend: 2023 $331 · 2024 $273 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Ardelyx, Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Ethicon US, LLC | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| EVOKE PHARMA, INC. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 2 | $15 |
Products named: REZDIFFRA, XIFAXAN, EOHILIA, IBSRELA, IQIRVO, ZENPEP, Echelon Circular, ENTYVIO.
Industry payments across FL — which companies pay providers there.
